Delivra Health Brands Inc.
DHB.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.40% | 20.19% | -5.33% | 30.57% | -15.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.40% | 20.19% | -5.33% | 30.57% | -15.27% |
| Cost of Revenue | 7.95% | 14.19% | -5.33% | 50.01% | -12.01% |
| Gross Profit | -6.98% | 25.93% | -5.32% | 13.91% | -18.24% |
| SG&A Expenses | -11.71% | -15.85% | 1.69% | 24.17% | 25.21% |
| Depreciation & Amortization | -91.80% | -11.75% | -6.04% | -2.80% | -4.02% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.41% | -2.01% | -2.39% | 30.34% | 3.20% |
| Operating Income | 94.63% | 254.01% | -47.97% | -29.40% | -247.89% |
| Income Before Tax | 81.14% | -67.47% | -40.54% | -21.61% | -308.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 81.14% | -67.47% | -40.54% | -21.61% | -308.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.14% | -67.47% | -40.54% | -21.61% | -308.01% |
| EBIT | 94.63% | 254.01% | -47.97% | -29.40% | -247.89% |
| EBITDA | 106.13% | 8,463.64% | -71.65% | -93.83% | -113.04% |
| EPS Basic | 82.05% | -60.00% | -40.30% | -3.33% | -274.63% |
| Normalized Basic EPS | 79.45% | 419.23% | -40.48% | -3.57% | -287.18% |
| EPS Diluted | 82.05% | -60.00% | -40.30% | -3.33% | -274.63% |
| Normalized Diluted EPS | 79.45% | 419.23% | -40.48% | -3.57% | -287.18% |
| Average Basic Shares Outstanding | 3.99% | -18.75% | 0.00% | 17.90% | 19.00% |
| Average Diluted Shares Outstanding | 3.99% | -18.75% | 0.00% | 17.90% | 19.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |